Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | GSK3A | P49840 | 2/20 | 0.30 |
| ▸ | GSK3B | P49841 | 2/20 | 0.30 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.30 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.30 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.30 |
| ▸ | AURKA | O14965 | 1/20 | 0.30 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.30 |
| ▸ | AURKC | Q9UQB9 | 1/20 | 0.30 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.30 |
| ▸ | CDK1 | P06493 | 1/20 | 0.30 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.30 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16382448 | 1.00 | KDM4E (0.35) | KDM4EMAPK1ATMGPR84ACHE | |
| SCHEMBL5196943 | 0.80 | TYMS (0.40) | KDM4EMAPK1ATMGPR84ACHE | |
| SCHEMBL5196941 | 0.80 | TYMS (0.40) | KDM4EMAPK1ATMGPR84ACHE | |
| SCHEMBL16378826 | 0.77 | KDM4E (0.34) | KDM4EMAPK1ATMGPR84ACHE | |
| SCHEMBL7511650 | 0.76 | MEN1 (0.35) | KDM4EMAPK1ATMGPR84ACHE | |
| SCHEMBL22057240 | 0.76 | MEN1 (0.35) | KDM4EMAPK1ATMGPR84ACHE | |
| SCHEMBL31738409 | 0.76 | MEN1 (0.35) | KDM4EMAPK1ATMGPR84ACHE | |
| SCHEMBL16382613 | 0.76 | MEN1 (0.35) | KDM4EMAPK1ATMGPR84ACHE | |
| SCHEMBL6654635 | 0.76 | MEN1 (0.35) | KDM4EMAPK1ATMGPR84ACHE | |
| SCHEMBL7649928 | 0.76 | MEN1 (0.35) | KDM4EMAPK1ATMGPR84ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3699178-A1 | PROCESS FOR PREPARING FLUOXASTROBIN | Arysta LifeScience Corporation (JP) | 2020-08-26 | — | — | EP | disclosed |
| EP-3019495-B1 | PROCESS FOR PREPARING FLUOXASTROBIN | ARYSTA LIFESCIENCE CORP (JP) | 2020-06-03 | — | — | EP | disclosed |
| US-9670171-B2 | Process for preparing fluoxastrobin | ARYSTA LIFESCIENCE CORP (JP) | 2017-06-06 | — | — | US | disclosed |
| US-20160237047-A1 | PROCESS FOR PREPARING FLUOXASTROBIN | ARYSTA LIFESCIENCE CORP (JP) | 2016-08-18 | — | — | US | disclosed |
| US-9193698-B2 | Process for preparing fluoxastrobin | ADVINUS THERAPEUTICS, LTD. (IN) | 2015-11-24 | — | — | US | disclosed |
| WO-2015006203-A1 | PROCESS FOR PREPARING FLUOXASTROBIN | ARYSTA LIFESCIENCE CORPORATION (JP) | 2015-01-15 | — | — | WO | disclosed |
| US-20150011753-A1 | PROCESS FOR PREPARING FLUOXASTROBIN | ARYSTA LIFESCIENCE CORPORATION (JP) | 2015-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160237047-A1 | PROCESS FOR PREPARING FLUOXASTROBIN | CYP4X1, MB, HAO2 | KDM4E 1730/4885MAPK1 2463/4885ATM 3231/4885 |
| US-20150011753-A1 | PROCESS FOR PREPARING FLUOXASTROBIN | CYP4X1, MB, HAO2 | KDM4E 1730/4885MAPK1 2463/4885ATM 3231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.